4.3 Letter

Postprandial effects of the phosphodiesterase-5 inhibitor tadalafil in people with well-controlled Type 2 diabetes mellitus: a randomized controlled trial

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Effect of Phosphodiesterase Inhibition on Insulin Resistance in Obese Individuals

Jennifer E. Ho et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)

Article Hematology

Reduced NO-cGMP Signaling Contributes to Vascular Inflammation and Insulin Resistance Induced by High-Fat Feeding

Norma O. Rizzo et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)

Article Endocrinology & Metabolism

Phosphodiesterase 5 Inhibition Improves β-Cell Function in Metabolic Syndrome

Kevin D. Hill et al.

DIABETES CARE (2009)

Article Endocrinology & Metabolism

Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin

MA Vincent et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)